| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267167.1 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.00113544 |
Resistant |
| ENSG00000267167.1 |
Avagacestat |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005465621 |
Resistant |
| ENSG00000267167.1 |
Avagacestat |
Breast invasive carcinoma |
0.038549816 |
Sensitive |
